Bristol Myers gets its first GI drug approval, and it comes from a longtime Celgene MS program
A former longtime Celgene program that saw a bumpy road to approval has picked up a new OK, with its new owners at Bristol Myers …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
